Promoter hypermethylation has been shown to suppress ITGA7 expression, leading to activation of the PI3K/AKT/NF-κB pathway and enhanced proliferation and migration in colorectal cancer (56). This evidence concerns the gene NFKB1 and colorectal cancer.